{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:53:49Z","timestamp":1789685629502,"version":"4.0.1"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:p>\n                           <jats:italic toggle=\"yes\">NTRK1\/2\/3<\/jats:italic> rearrangements have been identified as oncogenic drivers in a variety of tumors including those in the uterine cervix, and rarely, the uterine corpus. We report 2 cases of cervical sarcoma with <jats:italic toggle=\"yes\">NTRK<\/jats:italic> gene rearrangements. Case 1 was a 54-yr-old woman who presented with postmenopausal bleeding and a 5.4\u2009cm friable mass in the cervix. Microscopic examination of the tumor revealed proliferation of epithelioid and spindle cells arranged in alternating hypercellular and hypocellular areas, with subtle fibrosarcoma-like features. Coagulative tumor cell necrosis and readily recognizable mitoses (up to 40 mitotic figures per 10 high-power fields) were identified. Case 2 was a 52-yr-old woman who presented with abnormal vaginal bleeding and a 1.3\u2009cm cervical mass. The resected cervical tumor showed proliferation of spindled cells with fascicular and storiform growth pattern, infiltrating into the smooth muscle with entrapment of normal endocervical glands. The tumor cells displayed mild cytologic atypia and low mitotic activity (1 mitotic figure per 10 high-power fields). The mixed inflammatory infiltrate was seen throughout the lesion, mimicking morphology of inflammatory myofibroblastic tumor. Immunohistochemical staining for S100 and CD34 demonstrated variable expression in case 1 and uniformly diffuse positivity in case 2. The tumor cells in both cases were focally positive for CD10, Cyclin D1, ER, and PR, and negative for AE1\/AE3, desmin, SOX10, HMB-45. RNA fusion analysis identified <jats:italic toggle=\"yes\">SPECC1L-NTRK3<\/jats:italic> gene rearrangements in case 1 and <jats:italic toggle=\"yes\">TPM3-NTRK1<\/jats:italic> in case 2; DNA-based mutational analysis also revealed <jats:italic toggle=\"yes\">CDKN2A\/B<\/jats:italic> homozygous deletion in case 1. Despite accumulating literature on <jats:italic toggle=\"yes\">NTRK<\/jats:italic> fusion mesenchymal tumors in gynecologic pathology, these tumors are still rare and lack well-established morphologic diagnostic criteria. Diagnostic and clinical recognition of these tumors is critical given the potential patient benefit from targeted therapy.<\/jats:p>","DOI":"10.1097\/pgp.0000000000000834","type":"journal-article","created":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T10:08:16Z","timestamp":1635761296000},"page":"642-648","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":29,"title":["NTRK-Fusion Sarcoma of the Uterine Cervix: Report of 2 Cases With Comparative Clinicopathologic Features"],"prefix":"10.1097","volume":"41","author":[{"given":"Neshat","family":"Nilforoushan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Wethington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiro","family":"Nonogaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Vang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,29]]},"reference":[{"key":"R1-20250802","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"R2-20250802","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature09336","article-title":"Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not","volume":"467","author":"Nikoletopoulou","year":"2010","journal-title":"Nature"},{"key":"R3-20250802","first-page":"1","article-title":"Growth, survival and migration: the Trk to cancer","volume":"115","author":"Rubin","year":"2003","journal-title":"Cancer Treat Res"},{"issue":"suppl 8","key":"R4-20250802","doi-asserted-by":"crossref","first-page":"viii5","DOI":"10.1093\/annonc\/mdz383","article-title":"Tropomyosin receptor kinase (TRK) biology and the role of NTRK gene fusions in cancer","volume":"30","author":"Amatu","year":"2019","journal-title":"Ann Oncol"},{"key":"R5-20250802","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41379-019-0324-7","article-title":"NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls","volume":"33","author":"Solomon","year":"2020","journal-title":"Mod Pathol"},{"key":"R7-20250802","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.pathol.2020.02.004","article-title":"NTRK-rearranged mesenchymal tumours: diagnostic challenges, morphological patterns and proposed testing algorithm","volume":"52","author":"Wong","year":"2020","journal-title":"Pathology"},{"key":"R8-20250802","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/gcc.22846","article-title":"Emerging soft tissue tumors with kinase fusions: an overview of the recent literature with an emphasis on diagnostic criteria","volume":"59","author":"Antonescu","year":"2020","journal-title":"Genes Chromosomes Cancer"},{"key":"R9-20250802","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/gcc.22910","article-title":"NTRK and other recently described kinase fusion positive uterine sarcomas: a review of a group of rare neoplasms","volume":"60","author":"Croce","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"R10-20250802","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1097\/PAS.0000000000001055","article-title":"NTRK fusions define a novel uterine sarcoma subtype with features of fibrosarcoma","volume":"42","author":"Chiang","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R11-20250802","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/his.14069","article-title":"NTRK fusion cervical sarcoma: a report of three cases, emphasising morphological and immunohistochemical distinction from other uterine sarcomas, including adenosarcoma","volume":"77","author":"Rabban","year":"2020","journal-title":"Histopathology"},{"key":"R12-20250802","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/PGP.0000000000000669","article-title":"NTRK-rearranged cervical sarcoma: expanding the clinicopathologic spectrum","volume":"40","author":"Hodgson","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R13-20250802","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41379-018-0184-6","article-title":"Uterine and vaginal sarcomas resembling fibrosarcoma: a clinicopathological and molecular analysis of 13 cases showing common NTRK-rearrangements and the description of a COL1A1-PDGFB fusion novel to uterine neoplasms","volume":"32","author":"Croce","year":"2019","journal-title":"Mod Pathol"},{"key":"R14-20250802","doi-asserted-by":"crossref","first-page":"e00246","DOI":"10.1016\/j.crwh.2020.e00246","article-title":"TMP3-NTRK1 rearranged uterine sarcoma: a case report","volume":"28","author":"Boyle","year":"2020","journal-title":"Case Rep Womens Health"},{"key":"R15-20250802","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/PGP.0000000000000702","article-title":"S100 and Pan-Trk staining to report NTRK fusion-positive uterine sarcoma: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting","volume":"40","author":"Chiang","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"R16-20250802","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41379-018-0118-3","article-title":"Molecular characterization of cancers with NTRK gene fusions","volume":"32","author":"Gatalica","year":"2019","journal-title":"Mod Pathol"},{"key":"R17-20250802","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/PAS.0000000000000677","article-title":"ETV6-NTRK3 is expressed in a subset of ALK-negative inflammatory myofibroblastic tumors","volume":"40","author":"Alassiri","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"R18-20250802","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1177\/0300060518780873","article-title":"Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report","volume":"46","author":"Takahashi","year":"2018","journal-title":"J Int Med Res"},{"key":"R19-20250802","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1158\/2159-8290.CD-15-0443","article-title":"An oncogenic NTRK fusion in a patient with soft-tissue sarcoma with response to the tropomyosin-related kinase inhibitor LOXO-101","volume":"5","author":"Doebele","year":"2015","journal-title":"Cancer Discov"},{"key":"R20-20250802","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/PAS.0000000000001062","article-title":"Pan-Trk immunohistochemistry identifies NTRK rearrangements in pediatric mesenchymal tumors","volume":"42","author":"Rudzinski","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R21-20250802","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1038\/s41379-020-00705-6","article-title":"Targeted RNA expression profiling identifies high-grade endometrial stromal sarcoma as a clinically relevant molecular subtype of uterine sarcoma","volume":"34","author":"Momeni-Boroujeni","year":"2021","journal-title":"Mod Pathol"},{"key":"R22-20250802","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/gcc.22671","article-title":"A novel group of spindle cell tumors defined by S100 and CD34 co-expression shows recurrent fusions involving RAF1, BRAF, and NTRK1\/2 genes","volume":"57","author":"Suurmeijer","year":"2018","journal-title":"Genes Chromosomes Cancer"},{"key":"R23-20250802","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N Engl J Med"}],"container-title":["International Journal of Gynecological Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:03:23Z","timestamp":1754161403000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PGP.0000000000000834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,29]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pgp.0000000000000834","relation":{},"ISSN":["0277-1691"],"issn-type":[{"value":"0277-1691","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,29]]}}}